Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GATA3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | DCK | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | MAK16 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | DNAJC8 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | ZNF512 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | CNTN3 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
mRNA | CFLAR | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | TBC1D9 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | TOP3B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | HMX2 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |